Company / Accounts Receivable
VYCOR MEDICAL INC Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$218.9K
FY2025
5-year range
$126.1K / $245.3K
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 10 years, ranging from $110,422 in FY2017 to $274,551 in FY2019.
Based on SEC 10-K filings.
$218,891 in FY2025 with a 5-year CAGR of +6.6%.
Remained stable around $218,891 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +6.6%, indicating consistent growth.
- In FY2025, accounts receivable decreased 10.8% year-over-year.
- Peak accounts receivable was recorded in FY2019.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $218.9K | -10.8% |
| FY2024 | $245.3K | +14.0% |
| FY2023 | $215.2K | +37.8% |
| FY2022 | $156.2K | +23.9% |
| FY2021 | $126.1K | -20.8% |
| FY2020 | $159.2K | -42.0% |
| FY2019 | $274.6K | +6.6% |
| FY2018 | $257.5K | +133.2% |
| FY2017 | $110.4K | -25.8% |
| FY2016 | $148.8K | +20.2% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026